Patent ID: 7148213

Claim:
A method for treating a gynecological myoma comprising administering to a human in need thereof an antigestagenically effective amount of a 17α-fluoroalkyl steroid of general formula I in which R 1 stands for a methyl or ethyl group, R 2 stands for a radical of formula C n F m H o , whereby n is 2, 3, 4, 5 or 6, m>1 and m+o=2n+1, R 3 stands for a free etherified or esterified hydroxy group, R 4 and R 5 each stand for a hydrogen atom, together for an additional bond or a methylene group, St stands for a steroidal ABC-ring system of partial formula A, B or C in which R 6 means a hydrogen atom, a straight-chain C 1 –C 4 alkyl group or branched C 3 –C 4 alkyl group or a halogen atom, R 7 means a hydrogen atom, a straight-chain C 1 –C 4 alkyl group or a branched C 3 –C 4 alkyl group, or if St stands for a steroidal ABC-ring system A or B, in addition R 6 and R 7 together mean an additional bond, X means an oxygen atom, a hydroxyimino grouping ═N—OH or two hydrogen atoms, R 8 means a radical Y or an aryl radical that is optionally substituted in several places with a group Y, whereby Y is a hydrogen atom, a halogen atom, an —OH, —NO 2 , —N 3 , —CN, —NR 9a R 9b , —NHSO 2 R 9 , —CO 2 R 9 , C 1 –C 10 alkyl, C 1 –C 10 alkoxy, C 1 –C 10 alkanoyloxy, benzoyloxy, C 1 –C 10 alkanoyl, C 1 –C 10 hydroxyalkyl or benzoyl group, and R 9a and R 9b are the same or different and represent a hydrogen atom or a C 1 –C 10 alkyl group, and R 9 is a hydrogen atom or a C 1-10 alkyl group, or for a —NR 9a R 9b radical, also a physiologically compatible salt thereof with an acid, or for a —CO 2 R 9 radical in which R 9 is hydrogen, also a physiologically compatible salt thereof with a base.